LIF and breast carcinoma: We further used the results from a group of breast cancer patients who received 18F-fluorodeoxyglucose (18F-FDG) microPET scans to evaluate the impact of LIF overexpression on glucose uptake in breast tumors of breast cancer patients in vivo.